Veeva Systems (VEEV) Resumen de Acciones
Veeva Systems Inc. ofrece software basado en la nube para la industria de las ciencias de la vida en Norteamérica, Europa, Asia-Pacífico, Oriente Medio, África y Latinoamérica. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 2/6 |
| Crecimiento futuro | 2/6 |
| Rendimiento pasado | 5/6 |
| Salud financiera | 6/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en VEEV a partir de nuestros controles de riesgos.
VEEV Community Fair Values
Create NarrativeSee what 166 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de Veeva Systems Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$171.60 |
| Máximo en las últimas 52 semanas | US$310.50 |
| Mínimo de 52 semanas | US$148.05 |
| Beta | 1.1 |
| Cambio en 1 mes | -0.66% |
| Variación en 3 meses | -15.85% |
| Cambio de 1 año | -27.44% |
| Variación en 3 años | -4.19% |
| Variación en 5 años | -33.99% |
| Variación desde la OPV | 361.79% |
Noticias y actualizaciones recientes
VEEV: AI Moat And Subscription Resilience Will Support Premium Multiple
Analysts have trimmed the Veeva Systems price target slightly, with the model fair value moving from about $270.93 to $264.46, as modestly lower assumed future P/E multiples more than offset largely unchanged growth and margin expectations. Analyst Commentary Recent Street research around Veeva Systems shows a split view, with many firms trimming price targets while still pointing to solid execution and specific areas of uncertainty that could influence the valuation over time.VEEV: AI And Subscription Resilience Will Support Premium Software Multiple
Analysts trimmed the blended Veeva Systems price target by aligning with sector wide software multiple compression, even as they point to strong Q4 execution, resilient subscription growth, and an emerging AI and product pipeline as key longer term supports. Analyst Commentary Recent Street research around Veeva Systems reflects a mix of optimism on execution and growth, alongside more cautious views on competitive risk, AI impact, and valuation.Veeva Systems: Growth Has More Legs Now
Apr 07VEEV: AI Adoption In R&D Workflows Will Support Durable Premium Outlook
Analysts have adjusted their price targets on Veeva Systems into a roughly $190 to $317 range, generally trimming prior targets by tens of dollars as software valuation multiples compress, even after what they describe as solid Q4 results and broadly constructive longer term fundamentals. Analyst Commentary Recent research paints a mixed but generally constructive picture for Veeva Systems, with most firms trimming price targets while still pointing to solid execution and durable fundamentals.Recent updates
VEEV: AI Moat And Subscription Resilience Will Support Premium Multiple
Analysts have trimmed the Veeva Systems price target slightly, with the model fair value moving from about $270.93 to $264.46, as modestly lower assumed future P/E multiples more than offset largely unchanged growth and margin expectations. Analyst Commentary Recent Street research around Veeva Systems shows a split view, with many firms trimming price targets while still pointing to solid execution and specific areas of uncertainty that could influence the valuation over time.VEEV: AI And Subscription Resilience Will Support Premium Software Multiple
Analysts trimmed the blended Veeva Systems price target by aligning with sector wide software multiple compression, even as they point to strong Q4 execution, resilient subscription growth, and an emerging AI and product pipeline as key longer term supports. Analyst Commentary Recent Street research around Veeva Systems reflects a mix of optimism on execution and growth, alongside more cautious views on competitive risk, AI impact, and valuation.Veeva Systems: Growth Has More Legs Now
Apr 07VEEV: AI Adoption In R&D Workflows Will Support Durable Premium Outlook
Analysts have adjusted their price targets on Veeva Systems into a roughly $190 to $317 range, generally trimming prior targets by tens of dollars as software valuation multiples compress, even after what they describe as solid Q4 results and broadly constructive longer term fundamentals. Analyst Commentary Recent research paints a mixed but generally constructive picture for Veeva Systems, with most firms trimming price targets while still pointing to solid execution and durable fundamentals.VEEV: AI Adoption And CRM Commitments Will Support Durable Premium Outlook
We are trimming our Veeva Systems fair value estimate to $270.93 from $302.60, as analysts broadly reset price targets in response to sector wide software multiple compression and slightly more measured assumptions for revenue growth, margins, and future P/E multiples, despite generally solid Q4 results and guidance. Analyst Commentary Street research on Veeva Systems has become more mixed, with many firms cutting price targets while still acknowledging solid Q4 execution and robust profitability.VEEV: AI Execution And CRM Stability Will Support Durable Premium Outlook
Our fair value estimate for Veeva Systems has edged down from $308.63 to $302.60. This reflects a series of reduced Street price targets as analysts weigh maturing products, competitive pressures, software sentiment, and the balance of growth opportunities against current valuation.VEEV: Roche Commitment And CRM Retention Will Support Durable Premium Outlook
Our analyst fair value estimate for Veeva Systems has been trimmed slightly to $308.63. This reflects a modest reset in Street price targets as analysts balance concerns about slower growth in maturing products and competitive pressure with ongoing strengths in areas like Crossix, AI adoption, and large CRM wins such as Roche.
Rising Life Sciences Cloud Standardization And AI Adoption Will Support Strong Long Term Upside
Catalysts About Veeva Systems Veeva Systems provides cloud based software, data and consulting services to life sciences companies across commercial, R&D and manufacturing functions. What are the underlying business or industry changes driving this perspective?VEEV: Roche Rollout And CRM Retention Will Support Durable Premium Outlook
The analyst price target embedded in our Veeva Systems model edges slightly lower to about US$310 from roughly US$311. This reflects a blend of more cautious views on growth and competitive pressure, along with offsetting positive views on durable margins, CRM customer retention, and newer areas such as Crossix and early AI traction.VEEV: Roche Expansion And CRM Migrations Will Support Durable Premium Outlook
Analysts have trimmed their fair value estimate for Veeva Systems by about US$1 to US$310.98, reflecting modest adjustments to discount rate and growth assumptions while still pointing to what they see as durable growth drivers such as pharma CRM migrations, broader Vault adoption and newer areas like Crossix and AI. Analyst Commentary Recent Street research on Veeva Systems reflects a mix of optimism and caution, with differing views clustering around the durability of growth in CRM and Vault, the timing of pharma migrations, and how current valuation stacks up against execution and contract wins.VEEV: Roche Commitment And CRM Migrations Will Likely Sustain Premium Outlook
Analysts have modestly trimmed their blended price target for Veeva Systems to about $312 from roughly $321, reflecting a slightly higher discount rate and lower implied future multiple, even as they highlight accelerating CRM migrations, including Roche's global Vault CRM rollout, and improving long term growth and margin expectations. Analyst Commentary Street research remains broadly constructive on Veeva Systems, with recent target changes reflecting a recalibration of software multiples rather than a material shift in company specific fundamentals.Veeva Systems' (NYSE:VEEV) Performance Is Even Better Than Its Earnings Suggest
Dec 03
VEEV: Continued Momentum And New Commitments Will Likely Sustain Premium Outlook
Analysts have significantly raised their price targets on Veeva Systems, with recent updates moving targets as high as $380. They cite the company's strong sales growth prospects and solid momentum, driven by accelerating CRM customer commitments and new partnerships.Pharma Wins And New Partnerships Will Drive Cloud Momentum In Coming Quarters
Veeva Systems' analyst price target saw a significant increase, rising by more than $80 to reflect higher expectations for sales growth and ongoing customer commitments. Analysts cited the company’s strengthening position in CRM and positive momentum across key pharma relationships.IQVIA Resolution And Embedded AI Will Expand Digital Healthcare Cloud
Narrative Update on Veeva Systems: Analyst Price Target Revision Analysts have raised their fair value estimate for Veeva Systems to approximately $321 per share, up by nearly $4. They cited stronger than expected sales momentum, driven by new major customer commitments and continued growth in key business segments.Data Cloud Expansion And AI Efficiencies Will Drive Future Success
Analysts have raised their price target for Veeva Systems to $314.71, citing strong Q2 “beat and raise” results, momentum in both Commercial and R&D segments, successful Vault CRM rollouts with major pharma clients, and ongoing market share gains in life sciences CRM. Analyst Commentary Bullish analysts highlighted Veeva's strong “beat and raise” Q2 results, with both subscription and services revenues growing solidly year-over-year, driven by performance in both Commercial and R&D technology segments.If EPS Growth Is Important To You, Veeva Systems (NYSE:VEEV) Presents An Opportunity
Jul 11Veeva Systems (VEEV) Earnings Beat And AI Ambitions Shift The Investment Case
May 30Veeva Systems: Substantially Overvalued As Growth Slows
Apr 17Veeva Systems: Staying Buy Rated As VEEV Is Executing Well
Mar 19Veeva Systems: Solid Q4 With Margin Expansion
Mar 07Veeva Systems: Forget The Short-Term Volatility; The Long Term Is Promising
Jan 28Veeva Systems Q3: Making Progress With Vault CRM; Reiterating 'Strong Buy'
Dec 06Veeva Systems: Too Much Needs To Go Right, For Bull Case
Oct 08Veeva Systems: SMB Sector Is Growing Momentum
Sep 24Veeva: Q2, Robust Dev Cloud Growth, While Commercial Cloud Picks Up Steam
Aug 30
Expanding Clinical And CRM Frontiers Boosts Market Share And Revenue Prospects
Expansion in clinical operations and CRM offerings strengthens Veeva's competitive position and promises higher recurring revenue through customer confidence and adoption.Veeva Systems: Optimism Ahead Of Q2 Earnings Release
Aug 24Veeva Systems: Blend Of Value, Growth, And High Quality
Jul 29Rentabilidad de los accionistas
| VEEV | US Healthcare Services | Mercado US | |
|---|---|---|---|
| 7D | 6.5% | 2.7% | 0.8% |
| 1Y | -27.4% | -37.4% | 27.7% |
Rentabilidad vs. Industria: VEEV superó a la industria US Healthcare Services, que obtuvo un rendimiento del -37.4% el año pasado.
Rentabilidad vs. Mercado: VEEV obtuvo unos resultados inferiores a los del mercado US, que fueron del 27.7% el año pasado.
Volatilidad de los precios
| VEEV volatility | |
|---|---|
| VEEV Average Weekly Movement | 6.2% |
| Healthcare Services Industry Average Movement | 10.7% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.3% |
Precio estable de las acciones: VEEV no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de VEEV (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2007 | 7,928 | Peter Gassner | www.veeva.com |
Veeva Systems Inc. proporciona software basado en la nube para la industria de las ciencias de la vida en Norteamérica, Europa, Asia-Pacífico, Oriente Medio, África y Latinoamérica. La empresa ofrece Veeva Commercial Cloud, que comprende Veeva Vault CRM Suite para empresas farmacéuticas y biotecnológicas; Veeva Medical, que proporciona una fuente de contenido médico a través de múltiples canales y geografías; Veeva PromoMats, una solución integral de gestión de contenidos y activos digitales; y Veeva Crossix, una plataforma de análisis para marcas farmacéuticas. También proporciona Veeva Data Cloud, como Veeva OpenData, una solución de datos de referencia de clientes; Veeva Link, que proporciona datos profundos; Veeva Compass, que incluye datos de pacientes longitudinales y desidentificados; y Veeva CRM Pulse que proporciona acceso y métricas de compromiso multicanal.
Resumen de fundamentos de Veeva Systems Inc.
| Estadísticas fundamentales de VEEV | |
|---|---|
| Capitalización bursátil | US$25.47b |
| Beneficios(TTM) | US$908.91m |
| Ingresos (TTM) | US$3.20b |
¿Está VEEV sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de VEEV | |
|---|---|
| Ingresos | US$3.20b |
| Coste de los ingresos | US$782.02m |
| Beneficio bruto | US$2.41b |
| Otros gastos | US$1.50b |
| Beneficios | US$908.91m |
Últimos beneficios comunicados
Jan 31, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 5.56 |
| Margen bruto | 75.53% |
| Margen de beneficio neto | 28.44% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado VEEV a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/01 00:00 |
| Precio de las acciones al final del día | 2026/05/01 00:00 |
| Beneficios | 2026/01/31 |
| Ingresos anuales | 2026/01/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Veeva Systems Inc. está cubierta por 45 analistas. 28 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Joseph Vruwink | Baird |
| Saket Kalia | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |